Literature DB >> 24497564

Response to "efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up " Haematologica 2014;99(2):e17-18.

Elizabeth S Klings1, Elliott P Vichinsky, Claudia R Morris.   

Abstract

Entities:  

Keywords:  pulmonary hypertension; sildenafil; thalassemia

Mesh：

Substances：

Year:  2014        PMID： 24497564      PMCID： PMC3912978          DOI： 10.3324/haematol.2013.099861

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension.

Authors:  Roberto Littera; Giorgio La Nasa; Giorgio Derchi; Maria D Cappellini; Christy Y P Chang; Licinio Contu
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

2.  Pulmonary hypertension in thalassemia.

Authors:  Claudia R Morris; Elliott P Vichinsky
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

3.  Hemolysis-associated pulmonary hypertension in thalassemia.

Authors:  Claudia R Morris; Frans A Kuypers; Gregory J Kato; Lisa Lavrisha; Sandra Larkin; Titi Singer; Elliott P Vichinsky
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

4.  Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.

Authors:  Sylvia T Singer; Frans A Kuypers; Lori Styles; Elliott P Vichinsky; Drucella Foote; Howard Rosenfeld
Journal:  Am J Hematol       Date:  2006-09       Impact factor: 10.047

Review 5.  Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked.

Authors:  Dimitrios Farmakis; Athanasios Aessopos
Journal:  Circulation       Date:  2011-03-22       Impact factor: 29.690

6.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

7.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

8.  Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.

Authors:  Giorgio Derchi; Gian Luca Forni; Francesco Formisano; Maria Domenica Cappellini; Renzo Galanello; Giandomenico D'Ascola; Patrizio Bina; Carmelo Magnano; Martina Lamagna
Journal:  Haematologica       Date:  2005-04       Impact factor: 9.941

9.  Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.

Authors:  Claudia R Morris; Hae-Young Kim; Felicia Trachtenberg; John Wood; Charles T Quinn; Nancy Sweeters; Janet L Kwiatkowski; Alexis A Thompson; Patricia J Giardina; Jeanne Boudreaux; Nancy F Olivieri; John B Porter; Ellis J Neufeld; Elliott P Vichinsky
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

10.  Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.

Authors:  Roberto F Machado; Robyn J Barst; Nancy A Yovetich; Kathryn L Hassell; Gregory J Kato; Victor R Gordeuk; J Simon R Gibbs; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Reda E Girgis; Claudia R Morris; Erika B Rosenzweig; David B Badesch; Sophie Lanzkron; Onyinye Onyekwere; Oswaldo L Castro; Vandana Sachdev; Myron A Waclawiw; Rob Woolson; Jonathan C Goldsmith; Mark T Gladwin
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.